Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone.
Iskenderian A, Liu N, Deng Q, Huang Y, Shen C, Palmieri K, Crooker R, Lundberg D, Kastrapeli N, Pescatore B, Romashko A, Dumas J, Comeau R, Norton A, Pan J, Rong H, Derakhchan K, Ehmann DE.
Iskenderian A, et al. Among authors: derakhchan k.
Skelet Muscle. 2018 Oct 27;8(1):34. doi: 10.1186/s13395-018-0180-z.
Skelet Muscle. 2018.
PMID: 30368252
Free PMC article.